NO20052360L - Forbedrede formuleringer inneholdende substituerte imidazolderivater - Google Patents

Forbedrede formuleringer inneholdende substituerte imidazolderivater

Info

Publication number
NO20052360L
NO20052360L NO20052360A NO20052360A NO20052360L NO 20052360 L NO20052360 L NO 20052360L NO 20052360 A NO20052360 A NO 20052360A NO 20052360 A NO20052360 A NO 20052360A NO 20052360 L NO20052360 L NO 20052360L
Authority
NO
Norway
Prior art keywords
imidazole derivatives
substituted imidazole
containing substituted
formulations containing
improved formulations
Prior art date
Application number
NO20052360A
Other languages
English (en)
Other versions
NO336460B1 (no
Inventor
Juha-Matti Savola
Leon Paul Grother
Owen Murray
Susan Banbury
Paivi Juujarvi
Walter Lunsmann
Original Assignee
Scherer Technologies Inc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Inc R P filed Critical Scherer Technologies Inc R P
Publication of NO20052360L publication Critical patent/NO20052360L/no
Publication of NO336460B1 publication Critical patent/NO336460B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Forbedrede utformninger inneholdende substituerte imidazolderivater med den generelle formel (1), hvor Y er -CH2- eller -CO-, R1 er H, halogen eller hydroksy, R2 er H eller halogen, og R3 er H eller lavere alkyl (f.eks. Cl-C4-alkyl, fortrinnsvis C1- eller C2-alkyl), eller et farmasøytisk akseptabelt salt, så som et syreaddisjonssalt, f.eks. hydrokloridet, av en forbindelse med den generelle formel (I), er i fast hurtigdispergerings-doseringsform egnet for pregastrisk absorpsjon.
NO20052360A 2002-11-08 2005-05-12 Fast hurtigdispergerings-doseringsform inneholdende substituerte imidazolderivater NO336460B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0226076.8A GB0226076D0 (en) 2002-11-08 2002-11-08 Improved formulations containing substituted imidazole derivatives
PCT/US2003/034934 WO2004043439A1 (en) 2002-11-08 2003-11-03 Improved formulations containing substituted imidazole derivatives

Publications (2)

Publication Number Publication Date
NO20052360L true NO20052360L (no) 2005-06-06
NO336460B1 NO336460B1 (no) 2015-08-31

Family

ID=9947452

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052360A NO336460B1 (no) 2002-11-08 2005-05-12 Fast hurtigdispergerings-doseringsform inneholdende substituerte imidazolderivater

Country Status (15)

Country Link
US (1) US9717681B2 (no)
EP (1) EP1581192B1 (no)
JP (2) JP2006517516A (no)
KR (1) KR101170548B1 (no)
AU (1) AU2003287476B2 (no)
CA (1) CA2503630C (no)
ES (1) ES2392967T3 (no)
GB (1) GB0226076D0 (no)
IL (1) IL168257A (no)
MX (1) MXPA05004745A (no)
NO (1) NO336460B1 (no)
NZ (1) NZ539731A (no)
PL (1) PL214226B1 (no)
RU (1) RU2349305C2 (no)
WO (1) WO2004043439A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102332276A (zh) * 2003-12-01 2012-01-25 索尼株式会社 光盘用母盘的制造方法以及光盘用母盘
US7972621B2 (en) * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
US8268791B2 (en) 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US8545879B2 (en) 2009-08-31 2013-10-01 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam
TR201902233T4 (tr) 2009-10-30 2019-03-21 Ix Biopharma Ltd Hızlı çözünen katı dozaj formu.
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
EP4243796A4 (en) 2020-11-16 2025-01-22 Orcosa Inc. IMPROVED USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB211423A (en) 1923-10-06 1924-02-21 Leopold Seeger Improved means for locking nuts
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
NO852655L (no) 1985-06-05 1986-12-08 Bio Data Corp Fremgangsmaate ved fremstilling av koaguleringsreagens for blodplasma i mikrokonsentrert tablettform.
US4855326A (en) 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
JPH02121919A (ja) * 1988-10-28 1990-05-09 Grelan Pharmaceut Co Ltd 柔軟性を有する錠剤
GB2225782A (en) * 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
US4968692A (en) * 1989-01-06 1990-11-06 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Attenuation of ethyl alcohol intoxication with alpha-2 adrenoceptor antagonists
US4946684A (en) 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
ATE145551T1 (de) 1989-10-02 1996-12-15 Cima Labs Inc Brausedosisform sowie verfahren zu deren verabreichung
GB9127050D0 (en) 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
ATE172637T1 (de) 1991-12-24 1998-11-15 Yamanouchi Pharma Co Ltd Intrabukkal desintegrierende zubereitung und ihre herstellung
US5298261A (en) 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
GB9312669D0 (en) * 1993-06-18 1993-08-04 Orion Yhtymae Oy New opticla isomers
US6726928B2 (en) * 1994-10-28 2004-04-27 R.P. Scherer Technologies, Inc. Process for preparing solid dosage forms for unpalatable pharmaceuticals
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
CA2258159C (en) 1996-06-14 2006-03-21 Kyowa Hakko Kogyo Co., Ltd. Intraorally rapidly disintegrable tablet
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US5976577A (en) * 1997-07-11 1999-11-02 Rp Scherer Corporation Process for preparing fast dispersing solid oral dosage form
FR2781152B1 (fr) 1998-07-20 2001-07-06 Permatec Tech Ag Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation
JP2000095674A (ja) 1998-09-22 2000-04-04 Sato Pharmaceutical Co Ltd 口腔内崩壊時間短縮化錠剤の製造方法及び装置
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
GB9910505D0 (en) 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
US6284270B1 (en) 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
FR2798289B1 (fr) 1999-09-15 2004-12-31 Cll Pharma Formes galeniques a delitement rapide en bouche et leur procede de preparation
US6375982B1 (en) 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
ATE536869T1 (de) 2001-10-12 2011-12-15 Monosolrx Llc Auf glucan-film basierte wirkstoffverabreichungssysteme

Also Published As

Publication number Publication date
EP1581192A1 (en) 2005-10-05
JP2012051941A (ja) 2012-03-15
AU2003287476B2 (en) 2008-11-20
AU2003287476A1 (en) 2004-06-03
PL214226B1 (pl) 2013-07-31
WO2004043439A1 (en) 2004-05-27
PL375565A1 (en) 2005-11-28
US20060134194A1 (en) 2006-06-22
EP1581192A4 (en) 2009-12-02
US9717681B2 (en) 2017-08-01
RU2005117626A (ru) 2006-01-20
NO336460B1 (no) 2015-08-31
KR20050086458A (ko) 2005-08-30
NZ539731A (en) 2008-06-30
EP1581192B1 (en) 2012-08-08
RU2349305C2 (ru) 2009-03-20
MXPA05004745A (es) 2005-08-03
CA2503630C (en) 2013-07-30
IL168257A (en) 2014-04-30
ES2392967T3 (es) 2012-12-17
KR101170548B1 (ko) 2012-08-01
CA2503630A1 (en) 2004-05-27
JP2006517516A (ja) 2006-07-27
GB0226076D0 (en) 2002-12-18
HK1080282A1 (en) 2006-04-21
JP5474033B2 (ja) 2014-04-16

Similar Documents

Publication Publication Date Title
AP1965A (en) Tropane derivatives useful in therapy.
DK0620216T3 (da) Benzamidderivater og deres anvendelse som vasopressinantagonister
NO20101069L (no) Anvendelse av visse NMDA-affinitetsantagonister som antidepressiva
ATE107306T1 (de) 3-pyrrolidinylthio-1-azabicyclo (3.2.0)hept-2-en- 2-carbonsäure-verbindungen.
DE68925223D1 (de) 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-en-2-carbonsäure-Verbindungen
DE69008366D1 (de) 2-Aminopyrimidinon-Derivate.
ATE109149T1 (de) 3-pyrrolidinylthio-1-azabicyclo(3.2.0>-hept-2-e - 2-carbonsäureverbindungen.
DK0928788T3 (da) Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler
EE05103B1 (et) Famatseutilised kompositsioonid, mis sisaldavad asetidiini derivaate, asetidiini derivaadid ja nende valmistamise meetodid
DK129282A (da) Fremgangsmaade til fremstilling af indolylethylderivater
NO943894L (no) Galantaminderivater, en fremgangsmåte for fremstilling samt deres anvendelse som medikamenter
DK0437030T3 (da) Anvendelse af 4-substituerede imidazoler til nedsættelse af det intraoculære tryk
NO20022124L (no) Imidazopyridinderivater som fosfodiesterase VII-inhibitorer
CA2238875A1 (en) Tri-aryl ethane derivatives as pde iv inhibitors
NO20000722L (no) 2-(4-aryl eller heteroaryl-piperazin-1-ylmetyl)-1H- indolderivater
NO20060147L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20050666L (no) 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
DK0570294T3 (da) 2-formylpyridinthiosemicarbazonderivater, deres fremstilling og deres anvendelse som antitumormiddel
NO20025035D0 (no) Oksadiazolderivater som har anticancer-effekter
NO20054787D0 (no) Indenderivater som farmasotiske midler
NO20062491L (no) Benzoksazinderivter og deres anvendelse
NZ516100A (en) Streptogramin derivatives, preparation and compositions containing them
AU2001269540A1 (en) Serotonin reuptake inhibitors
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
NO20053483L (no) 4-Anilinokinazolinderivater for behandling av unormal cellevekst

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees